- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 19, 2026 | 7.75M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 7.79M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 3.05M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$141.86K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.34M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $38.89K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$8.27M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$7.19M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$12.18M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$22.9M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $13.6M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $11.98M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.36M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $783.19K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $5.33M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.8M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.18 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.30 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.18 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $3.06 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.46M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.78M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $402.39K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $1.35M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.43M |
| Net Income | Q1 2026 · Mar 31, 2025 | $9.19M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.77M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$3.13M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $83.73K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.7K |
| Revenue | Q1 2026 · Mar 31, 2026 | $85.43K |